RESULTS
75 CRSwNP patients participated in the study. 2 patients in rh-bFGF
nasal-spray group and 1 patient in rh-bFGF nasal-drop group lost
follow-up. 72 patients completed 1 year follow-up(FigureS1). The
baseline information of the three groups matched well(Table 1).